Table 2

 Prognostic factors associated with the clinical cure rate 7–10 days after the end of treatment using a stepwise logistic model (ITT population)

ParameterOdds ratioProbability95% Confidence interval
Lower limitUpper limit
There was no interaction between treatment and any of the individual factors (cardiopulmonary, p = 0.241; FEV1, p = 0.452; number of AECBs in previous year, p = 0.547).
Treatment (0 = comparator; 1 = moxifloxacin)1.4850.0151.0792.044
Cardiopulmonary disease (0 = no; 1 = yes)0.5850.0160.3780.903
FEV1 (%) at enrolment (0 = ⩾50; 1 = <50)0.482<0.0010.3490.666
Number of AECBs in previous year (0 = 2–3; 1 = ⩾4)0.6840.0320.4830.967